Related Experiment Video
Updated: Jul 17, 2026
09:35
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Gene therapy for hemophilia A.
1Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, MD11, 04-08, Singapore 117597. surgsu@nus.edu.sg
Discovery Medicine
|January 20, 2007
Summary
Gene therapy for hemophilia A shows promise despite past challenges. Advances in gene delivery and animal models offer new hope for effective treatments for this bleeding disorder.
Area of Science:
- Hematology
- Genetics
- Biotechnology
Background:
- Hemophilia A is an X-linked bleeding disorder resulting from Factor VIII deficiency.
- Current treatments with Factor VIII concentrate have limitations.
- Previous Factor VIII gene therapy trials showed insufficient efficacy, halting further development.
Purpose of the Study:
- To review the current status and future prospects of gene therapy for hemophilia A.
- To highlight the impact of advancements in gene delivery vectors and preclinical models.
Main Methods:
- Review of existing literature on hemophilia A treatments.
- Analysis of outcomes from past Factor VIII gene therapy clinical trials.
- Assessment of progress in gene therapy vector development and animal models.
Main Results:
- Existing Factor VIII therapies are effective but have drawbacks.
- Early gene therapy trials yielded modest results and were discontinued.
- Significant progress has been made in gene delivery systems and relevant animal models.
Conclusions:
- Despite past setbacks, hemophilia A gene therapy remains a critical research area.
- Ongoing advancements in technology and preclinical models are crucial for future success.
- Further pursuit of gene therapy holds potential for improved hemophilia A treatment.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...